124 related articles for article (PubMed ID: 12099074)
21. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
Paul C; Solignac M
Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
[No Abstract] [Full Text] [Related]
22. A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis.
Yazici Y; Erkan D; Lockshin MD
Clin Exp Rheumatol; 2000; 18(6):732-4. PubMed ID: 11138337
[TBL] [Abstract][Full Text] [Related]
23. [Etanercept].
Mühlhäuser U; Münzel F; Eschenhagen T
Dtsch Med Wochenschr; 2003 Aug; 128(34-35):1775-8. PubMed ID: 12934172
[No Abstract] [Full Text] [Related]
24. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
Mikhail M; Weinberg JM; Smith BL
Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
[No Abstract] [Full Text] [Related]
25. Etanercept, anticytokines and mania.
Kaufman KR
Int Clin Psychopharmacol; 2005 Jul; 20(4):239-41. PubMed ID: 15933486
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of psoriatic arthritis with TNF alpha-antagonists].
Antoni C; Manger B
Z Rheumatol; 2003 Jun; 62(3):235-9. PubMed ID: 12827399
[TBL] [Abstract][Full Text] [Related]
27. Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept.
van Luijn JC; Danz M; Bijlsma JW; Gribnau FW; Leufkens HG
Scand J Rheumatol; 2011 May; 40(3):183-91. PubMed ID: 20858147
[TBL] [Abstract][Full Text] [Related]
28. Marked hypertriglyceridemia upon treatment with etanercept.
Haroon M; Devlin J
Joint Bone Spine; 2009 Oct; 76(5):570-1. PubMed ID: 19303341
[No Abstract] [Full Text] [Related]
29. [Innovative therapeutic options for psoriatic arthritis: TNFalpha inhibitors].
Lehnen M; Goos M; Dissemond J
Dtsch Med Wochenschr; 2004 Mar; 129(12):634-8. PubMed ID: 15011134
[No Abstract] [Full Text] [Related]
30. The diagnosis and management of psoriatic arthritis in a professional football player presenting with a knee effusion: a case report.
Brophy RH; MacKenzie CR; Gamradt SC; Barnes RP; Rodeo SA; Warren RF
Clin J Sport Med; 2008 Jul; 18(4):369-71. PubMed ID: 18614892
[No Abstract] [Full Text] [Related]
31. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
Pomerantz RG; Mody E; Husni ME; Qureshi AA
J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
[TBL] [Abstract][Full Text] [Related]
32. Guideline for anti-TNF-alpha therapy in psoriatic arthritis.
Kyle S; Chandler D; Griffiths CE; Helliwell P; Lewis J; McInnes I; Oliver S; Symmons D; McHugh N;
Rheumatology (Oxford); 2005 Mar; 44(3):390-7. PubMed ID: 15695305
[No Abstract] [Full Text] [Related]
33. [The role of biological agents in the treatment of psoriatic arthritis, literature review].
Koó E; Brodszky V; Péntek M; Ujfalussy I; Nagy MB; Gulácsi L
Orv Hetil; 2006 Oct; 147(41):1963-70. PubMed ID: 17120686
[TBL] [Abstract][Full Text] [Related]
34. Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis.
Besada E; Njålla RJ; Nossent JC
Rheumatol Int; 2013 Oct; 33(10):2687-9. PubMed ID: 22886470
[TBL] [Abstract][Full Text] [Related]
35. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].
Salvarani C; Olivieri I; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M
Reumatismo; 2004; 56(3):133-4, 136-8. PubMed ID: 15470517
[No Abstract] [Full Text] [Related]
36. Treatment of rheumatoid arthritis with etanercept.
Genovese MC; Kremer JM
Rheum Dis Clin North Am; 2004 May; 30(2):311-28, vi-vii. PubMed ID: 15172043
[TBL] [Abstract][Full Text] [Related]
37. Activation of nuclear factor kappa B and mitogen activated protein kinases in psoriatic arthritis before and after etanercept treatment.
Lories RJ; Derese I; Luyten FP; de Vlam K
Clin Exp Rheumatol; 2008; 26(1):96-102. PubMed ID: 18328153
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
[TBL] [Abstract][Full Text] [Related]
39. Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection.
Linardaki G; Katsarou O; Ioannidou P; Karafoulidou A; Boki K
J Rheumatol; 2007 Jun; 34(6):1353-5. PubMed ID: 17552060
[TBL] [Abstract][Full Text] [Related]
40. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
Rokhsar C; Rabhan N; Cohen SR
J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]